Financial Burden of Treatment of Transfusion Dependent Thalassemia
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Zhang R, Zhang S, Ming J, Xie J, Liu B, Jiang W BMC Nurs. 2024; 23(1):151.
PMID: 38439062 PMC: 10910837. DOI: 10.1186/s12912-024-01826-y.
References
1.
Mandal S, Sodhi K, Bansal D, Sinha A, Bhatia A, Trehan A
. MRI for Quantification of Liver and Cardiac Iron in Thalassemia Major Patients: Pilot Study in Indian Population. Indian J Pediatr. 2017; 84(4):276-282.
DOI: 10.1007/s12098-017-2310-8.
View
2.
Weidlich D, Kefalas P, Guest J
. Healthcare costs and outcomes of managing β-thalassemia major over 50 years in the United Kingdom. Transfusion. 2016; 56(5):1038-45.
DOI: 10.1111/trf.13513.
View
3.
Verma I, Saxena R, Kohli S
. Past, present & future scenario of thalassaemic care & control in India. Indian J Med Res. 2011; 134:507-21.
PMC: 3237251.
View
4.
Esmaeilzadeh F, Azarkeivan A, Emamgholipour S, Akbari Sari A, Yaseri M, Ahmadi B
. Economic Burden of Thalassemia Major in Iran, 2015. J Res Health Sci. 2016; 16(3):111-115.
PMC: 7191027.
View
5.
Moirangthem A, Phadke S
. Socio-demographic Profile and Economic Burden of Treatment of Transfusion Dependent Thalassemia. Indian J Pediatr. 2017; 85(2):102-107.
DOI: 10.1007/s12098-017-2478-y.
View